PAS
BEAM icon

Point72 Asia (Singapore)’s Beam Therapeutics BEAM Stock Holding History

Point72 Asia (Singapore)’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,708
Closed -$191K – 884
2024
Q4 		$191K Buy
+7,708
New +$197K 0.05% 250
2024
Q2 		– Sell
-15,496
Closed -$512K – 1069
2024
Q1 		$512K Buy
+15,496
New +$483K 0.13% 162

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Point72 Asia (Singapore)'s BEAM Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of Beam Therapeutics (BEAM) in Q1 2025, closing a stake of 7,708 shares — an estimated $191K sold.

Point72 Asia (Singapore) first reported a position in BEAM in Q1 2024 and held it in 2 quarters. The position peaked at $512K in Q1 2024. 238 funds tracked by Wall St. Rank hold BEAM as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining Beam Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 7,708 Beam Therapeutics shares in Q1 2025, an estimated $191K.
  • Point72 Asia (Singapore) first reported a position in Beam Therapeutics in Q1 2024 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s Beam Therapeutics position peaked at $512K in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.